EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION
https://doi.org/10.20996/1819-6446-2009-5-2-55-58
Abstract
Aim. To study effect of antihypertensive drugs on quality of life (QoL) of patients with stable arterial hypertension (HT).
Material and methods. Results of some studies with similar design involving totally 170 patients with HT, aged 57,2±8,8 y.o., were analyzed. HT duration was 11,2±8,3 years. Patients received antihypertensive monotherapy with diltiazem, amlodipine, enalapril, lisinopril, metoprolol and telmisartan during 1-3 months. 24-hour blood pressure (BP) monitoring, QoL was performed before and after treatment.
Results. All antihypertensive drugs significantly reduced systolic and diastolic BP and did not affect QoL. ACE inhibitors similarly improved QoL.
Conclusion. Antihypertensive drugs (diltiazem, amlodipine, enalapril, lisinnopril, metoprolol, telmisartan) do not worsen QoL of patients with HT.
About the Authors
G. F. Andreeva
State Research Center for Preventive Medicine of Rosmedtechnology
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Russian Federation
Petroverigsky per. 10, Moscow, 101990
A. D. Deev
State Research Center for Preventive Medicine of Rosmedtechnology
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Russian Federation
Petroverigsky per. 10, Moscow, 101990
V. M. Gorbunov
State Research Center for Preventive Medicine of Rosmedtechnology
Russian Federation
Petroverigsky per. 10, Moscow, 101990
Russian Federation
Petroverigsky per. 10, Moscow, 101990
References
1. Оганов Р.Г. Масленникова Г.Я. Смертность от сердечно-сосудистых и других хронических неинфекционных заболеваний среди трудоспособного населения России. Кардиоваскулярная терапия и профилактика 2002;(3):4-8.
2. Collins R.., MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50(2):272-98.
3. Staessen J.A., Gasowski J., Wang J.G. et al. Risk of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355(9207):865-72.
4. Hansson L., Zanchetti A., Carruters S.G. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351(9118):1755-62.
5. Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Артериальная гипертония. Информированность, лечение, контроль. Профилактика заболеваний и укрепление здоровья 2001;(2):3-7.
6. Леви Л., Андерсон А. Народонаселение, окружающая среда и качество жизни. М; Экономика; 1979.
7. Айвазян Т.А., Зайцев В.П. Исследование качества жизни больных гипертонической болезнью. Кардиология 1989;(9):43-6.
8. Beto J.A., Bansal V.K. Quality of life in treatment of hypertension. A metaanalysis of clinical trials. Am J Hypertens 1992;5(3):125-33.
9. Siegrist J., Junge A. Conceptual and methodological problems in research on the quality of life in clinical medicine. Soc Sci Med 1989;29(3):463-8.
10. Метелица В.И., Островская Т.П., Дуда С.Г. и др. Длительная монотерапия препаратами из четырех основных групп гипотензивных средств у больных с мягкой и умеренной артериальной гипертонией. Многоцентровое исследование «Каптоприл и качество жизни». Рабочая группа многоцентрового исследования «Каптоприл и качество жизни» («МИ-КЖ»). Тер арх 1995;67(6):15-20.
11. Zuther P., Witte K., Lemmer B. ABPM-FIT and CV-SORT: an easy-to-use software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Press Monit 1996; 1(4): 347-54.
12. de Bruin A.F., Buys M., de Witte L.P., Diederiks J.P. The sickness impact profile: SIP68, a short generic version. First evaluation of the reliability and reproducibility. J Clin Epidemiol 1994;47(8):863-71.
13. Chambers L.W., Macdonald L.A., Tugwell P. et al. The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol 1982;9(5):780-784.
14. Kind P., Carr-Hill R. The Nottingham health profile: a useful tool for epidemiologists? Soc Sci Med 1987;25(8):905-10.
15. Lim L.L., Valenti L.A., Knapp J.C. Et al. A self-administered quality-of-life questionnaire after acute myocardial infarction. J Clin Epidemiol 1993;46(11):1249-56.
16. Spitzer W.O., Dobson A.J., Hall J. et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 1981;34(12):585-97.
17. Llewellyn-Thomas H.A., Sutherland H.J., Hogg S.A. et al. Linear analogue self-assessment of voice quality in laryngeal cancer. J Chron Dis 1984;37(12):917-24.
18. Ware J. SF-36 health survey update. Spine 2000;25(24):3130-9.
19. The World Health Organization Quality of Life (WHOQOl)-BREF. World Health Organization; 2004. Available in http://www.who.int/substance_abuse/research_tools/en/russian_whoqol.pdf
20. Андреева Г.Ф., Деев А.Д., Горбунов В.М. Воздействие лизиноприла и эналаприла на качество жизни и суточный профиль артериального давления больных стабильной артериальной гипертензией. Рациональная Фармакотерапия в Кардиологии 2006;(2):32-5.
21. Crooq S.H., Levine S., Testa M.A. et al. The effect of antihypertensive therapy on the quality of life. N Engl J Med 1986;314(26):1657-64.
22. Pessano B., La Brocca A., Pozzallo G. et al. Antihypertensive efficacy and effects on quality of life of captopril in mild-to-moderate arterial hypertension [in Italian]. Minerva Med 1989;80(6):595–8.
23. Testa M.A., Anderson R.B., Nackley J.F., Hollenberg N.R. Quality of life and antihypertensive therapy in man. N Engl J Med 1993;328(13):907-13.
24. Андреева Г.Ф., Горбунов В.М., Айвазян Т.А. и др. Влияние телмисартана на психологический статус и качество жизни больных со стабильной артериальной гипертензией. Эксп клин фармакол 2004;(6):36-40.
25. Zubenko G.S., Nixon R.A. Mood-elevating effect of captopril in depressed patients. Am J Psychiatry 1984;141(1):110-1.
26. Costall B., Coughlan J., Horovitz Z.P. et al. The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Pharmacol Biochem Behav 1989;33(3):573-9.
27. Baranowska D., Brazsko J.J., Wisniewski K. Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats. Psychopharmacology 1983;81(3):247-51.
28. Pessina A.C., Boari L., De Dominicis E. et al. Efficacy, tolerability and influence on "quality of life" of nifedipine GITS versus amlodipine in elderly patients with mild-moderate hypertension. Blood Press 2001;10(3):176-83.
Review
For citations:
Andreeva G.F., Deev A.D., Gorbunov V.M. EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION. Rational Pharmacotherapy in Cardiology. 2009;5(2):55-58. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-2-55-58
Views:
1026
Email this article 